• Open to all meeting registrants
  • These programs are not affiliated with AASLD

AASLD provides an opportunity for registrants of The Liver Meeting® to attend independent symposia financially supported by the pharmaceutical industry. These symposia will take place following The Liver Meeting’s scheduled educational events on Saturday, November 9 after 7:30 pm; and Sunday, November 10 and Monday, November 11 after 6:30 pm.

Each of the symposia organizers has made a financial contribution in support of the educational mission of AASLD. This support allows symposia organizers access to The Liver Meeting’s attendees before the meeting by way of mail promotions and on specific evenings during the meeting following official AASLD functions. They also make many features of The Liver Meeting® possible and help maintain reasonable registration fees.

This support is gratefully acknowledged. This acknowledgement, however, does not constitute an endorsement of any product, nor AASLD oversight or endorsement of the content of the program. These programs are not affiliated with AASLD.

Visit the satellite symposia information center located on the Plaza Level of the Hynes Convention Center for more information and to register for any of the following events.

  • Saturday, November 9 -- 7:30 pm
  • Sunday, November 10 -- 6:30 pm
  • Monday, November 11 -- 6:30 pm

Hepatorenal Syndrome from A to Z: Updates to Guidelines and Patient Treatment Advances Explored

Supported by: Mallinckrodt Pharmaceuticals
Organized by: Medscape Education
CME provided by: Medscape, LLC
Location: Marriott Copley Boston – Salon G-K

On completion of this activity, should be able to:

  • Have increased knowledge regarding:
    • Current and emerging treatment approaches for HRS
    • Latest data on emerging treatment options for HRS
    • Guideline updates regarding diagnosis and treatment of HRS
  • Have greater competence related to:
    • Expedient recognition and diagnosis of patients with HRS
    • Safe and effective treatment strategies for patients with HRS according to guideline recommendations

For more information, visit their website.

Are Your Patients at Risk of Bleeding? A Case-Based Approach for Managing Thrombocytopenia in Chronic Liver Disease

Supported by: Shionogi
Organized by: Med-IQ
CME provided by: Med-IQ
Location: Marriott Copley Boston – Salon A-E

On completion of this activity, participants should be able to:

  • Evaluate clinical data and expert recommendations on platelet count thresholds for patients with CLD undergoing scheduled invasive procedures
  • Summarize the benefits and limitations associated with platelet transfusions and thrombopoietin-receptor agonists for the treatment of thrombocytopenia in patients with CLD
  • Identify treatment strategies for patients with CLD and thrombocytopenia based on their bleeding risks, platelet counts, coagulopathy status, and procedure type

For more information, call 866-858-7434 or email info@med-iq.com.